-
Darling Ingredients’ Health Brand Rousselot Announces Online Access to Research- and Technical-Grade X-Pure Gelatins through BIO INX
Irving, Texas, US, 13th March 2024 / Sciad Newswire / Darling Ingredients’ health brand Rousselot, a global leader in gelatin- and collagen-based solutions, announced today that its high-quality, research- and technical-grade gelatins are now available for online purchase in Canada, Europe, South Korea and the U.S. through BIO INX, a pioneering developer and distributor of…
-
Celebrating International Women’s Day: A Q&A with Maria Patey
A Q&A with Sciad’s Managing Partner, Maria Patey on International Women’s Day. What do you consider your strengths and proudest achievements in your career? Creativity, Resilience, Intuition; I trust my intuition – and when it comes to a crunch point, I go with my gut, unless there’s a clear reason to pause and re-consider. If…
-
Neobe Therapeutics raises over $2m for synthetic biology enabled tumour microenvironment remodelling
STEVENAGE, UK, 29 February 2024: Neobe Therapeutics, a pioneering synthetic biology startup at the forefront of immuno-oncology innovation, is thrilled to announce the successful closure of a $2.34M financing round. This significant financial milestone was achieved with the support of new investors Pioneer Group and 2048 Ventures, alongside existing backers Deep Science Ventures*, Cancer Research…
-
Celebrating International Women’s Day and tackling inequality at Discovery Park
Discovery Park to host two events to celebrate women in business and tackle challenges in women’s health. Sandwich, Kent, UK / 28th February 2024 / Discovery Park, Kent’s thriving life science community, is marking International Women’s Day by supporting women in business and tackling gender bias in healthcare. With female founded start-ups still struggling to…
-
HM Lord-Lieutenant of Cambridgeshire Opens Domainex’s New Biology Centre of Excellence and Presents the King’s Award for Enterprise
Cambridge, United Kingdom, 13th February 2024 / Domainex, a leading drug discovery and integrated medicines research partner based in Cambridge UK, opens a new Biology Centre of Excellence to further support collaborations with pharmaceutical and biotechnology companies, patient foundations and leading academic institutions globally. The grand opening on the 7th February was officiated by Mrs Julie Spence…
-
Watson-Marlow Fluid Technology Solutions to Showcase Fluid Path Product Range at ISPE Rocky Mountain and ISPE CaSA
Visit booth 70 at Rocky Mountain ISPE Vendor Show and booth 943 at ISPE CaSA Annual Tech Show to meet Watson-Marlow engineers and discuss the company’s expert fluid path solutions Devens, MA, US / 7th February 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS) will attend two ISPE events in February to showcase its fluid…
-
MultiOmic Health and Queen’s University Belfast join forces to transform diabetic kidney disease diagnosis
London, UK, 7th February 2024 / Sciad Newswire / MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, is embarking on a collaborative project with the Centre for Public Health at Queen’s University Belfast (QUB) in Northern Ireland to develop data-driven diagnostic tools for Diabetic Kidney Disease (DKD). The two-year project is partially funded by…
-
New Qdos H-FLO chemical metering and dosing pump offers higher flow rates for a wide range of dosing applications
Falmouth, UK, 31st January 2024 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS) has launched the Qdos™ H-FLO chemical metering and dosing pump, designed specifically for higher flow rates up to 600 L/h. Qdos H-FLO delivers the same outstanding accuracy and reliability as other Qdos pumps but for higher flow rates with a variety of pumpheads and…
-
Watson-Marlow to demonstrate latest fluid path technologies at MD&M West
Devens, MA, US / 30th January 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range specially designed for medical devices and diagnostic instruments at MD&M West in Anaheim, CA, from February 6-8. WMFTS will demonstrate its precision-engineered peristaltic…
-
Circadacare raises £1.3m to fund circadian lighting and monitoring technology to improve independent living
Newcastle, UK, 18th January 2024 / Sciad Newswire / Circadacare, an independent living technology company that integrates proven circadian light technology with a unique monitoring platform to enhance wellness and promote independent living, today announces that it has successfully raised £1.3 million in funding, led by Northstar Ventures, with contributions from both private and venture…